RESUMO
Viruses in the genus Capripoxvirus, family Poxviridae, cause sheeppox, goatpox and lumpy skin disease, which are the most serious poxvirus diseases of production animals. Despite the considerable threat that these viruses pose to livestock production and global trade in sheep, goats, cattle and their products, convenient and effective serodiagnostic tools are not readily available. To develop a more effective antibody detection capability, selected open reading frames from capripoxvirus DNA were amplified and expressed in Escherichia coli as His-tagged fusion proteins. By screening 42 candidate antigens, two sheeppox virus virion core proteins that were expressed efficiently, purified readily using affinity chromatography and reactive against capripoxvirus immune sera in an indirect enzyme-linked immunosorbent assay (ELISA) were identified. The ELISA performed favourably when sera from sheep and goats infected experimentally with virulent capripoxvirus isolates were tested, with sensitivity and diagnostic specificity ranging between 95 and 97%, but it was unable to detect antibodies reliably in vaccinated sheep or goats. Furthermore, no cross-reactivity with antibodies against orf virus was detected. This assay offers the prospect of a convenient and standardised ELISA-based serodiagnostic test, with no requirement for infectious reagents, that is well suited to high-throughput capripoxvirus surveillance on a flock or herd basis.
Assuntos
Anticorpos Antivirais/sangue , Antígenos Virais , Capripoxvirus/imunologia , Ensaio de Imunoadsorção Enzimática/métodos , Doenças das Cabras/diagnóstico , Infecções por Poxviridae/veterinária , Doenças dos Ovinos/diagnóstico , Animais , Antígenos Virais/genética , Capripoxvirus/genética , Clonagem Molecular , Escherichia coli/genética , Doenças das Cabras/imunologia , Cabras , Infecções por Poxviridae/diagnóstico , Proteínas Recombinantes/genética , Sensibilidade e Especificidade , Ovinos , Doenças dos Ovinos/imunologiaRESUMO
Sheeppox virus and goatpox virus cause systemic disease in sheep and goats that is often associated with high morbidity and high mortality. To increase understanding of the pathogenesis of these diseases, we undertook quantitative time-course studies in sheep and goats following intradermal inoculation of Nigerian sheeppox virus or Indian goatpox virus in their respective homologous hosts. Viremia, determined by virus isolation and real-time PCR, cleared within 2 to 3 weeks post inoculation. Peak shedding of viral DNA and infectious virus in nasal, conjunctival and oral secretions occurred between 10 and 14 days post inoculation, and persisted at low levels for up to an additional 3 to 6 weeks. Although gross lesions developed in multiple organ systems, highest viral titers were detected in skin and in discrete sites within oronasal tissues and gastrointestinal tract. The temporal distribution of infectious virus and viral DNA in tissues suggests an underlying pathogenesis that is similar to smallpox and monkeypox where greatest viral replication occurs in the skin. Our data demonstrate that capripoxvirus infections in sheep and goats provide additional and convenient models which are suitable not only for evaluation of poxvirus-specific vaccine concepts and therapeutics, but also study of poxvirus-host interactions.
Assuntos
Capripoxvirus/patogenicidade , Doenças das Cabras/patologia , Infecções por Poxviridae/veterinária , Doenças dos Ovinos/patologia , Eliminação de Partículas Virais , Animais , Capripoxvirus/isolamento & purificação , DNA Viral/análise , DNA Viral/sangue , DNA Viral/isolamento & purificação , Doenças das Cabras/virologia , Cabras/virologia , Especificidade de Órgãos , Reação em Cadeia da Polimerase , Infecções por Poxviridae/patologia , Infecções por Poxviridae/virologia , Doenças dos Ovinos/virologia , Viremia/veterinária , Viremia/virologiaRESUMO
Interest in DNA immunization of animals continues, despite the fact that immune responses induced by DNA vaccines are generally lower than those elicited by conventional vaccines. In attempts to enhance the immune response to DNA vaccines, individuals have tried a variety of immune modulators, cytokines, and costimulatory molecules, but these only boost immune responses marginally. These results clearly demonstrate that the major challenge to improving DNA-based vaccines is to improve the transfection efficiency. Gene gun and electroporation can increase transfection and improve immune responses significantly, but these technologies have not yet advanced to the stage of routine use in livestock. Hopefully, transfection efficiency can be increased further in a user-friendly manner to ensure that the benefits of using DNA vaccines become a reality.